Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.0100
-0.0010 (-10.00%)
Apr 20, 2026, 3:15 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 108.75 million as of April 20, 2026. Its market cap has increased by 81.52% in one year.
Market Cap
108.75M
Enterprise Value
59.65M
Revenue
6.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 108.75M, an increase of 111.13%. That is a compound annual growth rate of 2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 108.75M | 25.00% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 164.83M |
| Actinogen Medical | 143.66M |
| Island Pharmaceuticals | 106.41M |
| Immutep | 101.69M |
| Paradigm Biopharmaceuticals | 101.65M |
| Arovella Therapeutics | 97.91M |
| Botanix Pharmaceuticals | 97.57M |
| Cynata Therapeutics | 85.48M |